Enterobiotix Limited

SC559230 · Active

Company details

Type
Private Limited Company
Incorporated
2017-03-02
Country of origin
United Kingdom

Accounts & filings

Accounts last filed
2024-12-31 · FULL
Next accounts due
2026-09-30 in 117 days
Confirmation statement
last made up 2025-04-19 · next due 2026-05-0333 days overdue

View full filing history at Companies House →

Registered office

Phoenix House Phoenix Crescent
Strathclyde Business Park
Bellshill
Lanarkshire
Ml4 3nj

Peer comparison

Compared against 36 UK companies in SIC 72110 (Research and experimental development on biotechnology) within the Medium bracket (£1M–£10M net assets).

See where this company ranks

Included with the £1 AI analysis unlock — one payment unlocks both for this company. Yours forever.

Based on this company's latest filed accounts (to Mar 2022) · Balance sheet only — small-company filing, no public profit & loss.
Note: these are the most recent machine-readable accounts on file, but they're now over two years old — more recent filings may not yet be available in a readable format.

Unlock for £1

Compares this company to 36 UK peers in Medium bracket, by net assets, turnover, profitability, and more.

Financial health

Derived from the filed accounts to Mar 2022. Figures only — not advice.

See this company's financial health

£1 unlocks the liquidity & profitability ratios, risk signals, the AI analysis and peer comparison for this company. One payment, yours forever.

Based on this company's latest filed accounts (to Mar 2022) · Balance sheet only — small-company filing, no public profit & loss.
Note: these are the most recent machine-readable accounts on file, but they're now over two years old — more recent filings may not yet be available in a readable format.

Unlock for £1

Ratios and signals derived from this company's filed Companies House figures only.

Accounts

Based on this company's latest filed accounts (to Mar 2022) · Balance sheet only — small-company filing, no public profit & loss.
Note: these are the most recent machine-readable accounts on file, but they're now over two years old — more recent filings may not yet be available in a readable format.

Year ending Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Balance sheet
Fixed assets
 
 
 
 
£103,326
 
Current assets
£6,579,548
↑2.2%
£6,439,223
↓22.6%
£8,323,571
↑572.1%
£1,238,524
↑623.2%
£171,245
 
Cash
£5,272,264
↓4.2%
£5,501,965
↓31.1%
£7,991,106
↑578.0%
£1,178,613
↑771.5%
£135,245
 
Debtors
£1,307,284
↑39.5%
£937,258
↑214.8%
£297,695
↑499.5%
£49,656
↑37.9%
£36,000
 
Net current assets
£5,980,037
↑1.3%
£5,900,880
↓28.0%
£8,199,692
↑652.6%
£1,089,563
↑15720.6%
£6,887
 
Net assets
£9,383,894
↑49.1%
£6,291,812
↓24.2%
£8,296,862
↑628.6%
£1,138,663
↑933.1%
£110,213
 
Equity
£9,383,894
↑49.1%
£6,291,812
↓24.2%
£8,296,862
↑628.6%
£1,138,663
↑933.1%
£110,213
 
Other
Average employees
28
↑55.6%
18
↑63.6%
11
↑37.5%
8
↑33.3%
6
 

Source: filed iXBRL accounts at Companies House. P&L items are only published by medium and large companies; small companies file abridged or micro-entity accounts where the P&L is not public.

Industry (SIC codes)

72110 · Research and experimental development on biotechnology

Officers (18)

People with significant control (3)

Recent filings (15)

Showing the 15 most recent filings. View full filing history at Companies House.

Source: Companies House register